Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rmc-6236
Non-Small Cell Lung Carcinoma
Tango Therapeutics, Inc.
P1/2
CCC
(48)
Rmc-9805
Lung Cancer
Tango Therapeutics, Inc.
P1/2
CCC
(48)
rn0361
Familial Chylomicronemia Syndrome
Ikaria Bioscience Pty Ltd
P1/2
CCC
(48)
rn0361
Hypertriglyceridemia
Ikaria Bioscience Pty Ltd
P1/2
CCC
(48)
Rndp-001
Parkinson Disease
Kenai Therapeutics
P1/2
CCC
(48)
Rocbrutinib
Waldenstrom Macroglobulinemia
Guangzhou Lupeng Pharmaceutical Company LTD.
P1/2
CCC
(48)
Ro-Choep-21
ALK-Negative Anaplastic Large Cell Lymphoma
Fondazione Italiana Linfomi - ETS
P1/2
CCC
(48)
Ro-Choep-21
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS
P1/2
CCC
(48)
Roginolisib
Peripheral T-Cell Lymphoma, Not Otherwise Specified
The Lymphoma Academic Research Organisation
P1/2
CCC
(48)
rp-001
Neoplasm
Recurv Pharma Inc
P1/2
CCC
(48)
Rso-021
Pleural Neoplasm
RS Oncology LLC
P1/2
CCC
(48)
Rso-021
Malignant Pleural Mesothelioma
RS Oncology LLC
P1/2
CCC
(48)
Rso-021
Pleural Mesothelioma
RS Oncology LLC
P1/2
CCC
(48)
rtx001
Chronic Liver Failure
Resolution Therapeutics Limited
P1/2
CCC
(48)
rtx001
Fatty Liver Disease
Resolution Therapeutics Limited
P1/2
CCC
(48)
Ruxolitinib
Castration-Resistant Prostate Carcinoma
University of Michigan Rogel Cancer Center
P1/2
CCC
(48)
S230815
Developmental And Epileptic Encephalopathy
Institut de Recherches Internationales Servier
P1/2
CCC
(48)
s241656
Histiocytic And Dendritic Cell Neoplasm
Institut de Recherches Internationales Servier
P1/2
CCC
(48)
s241656
Histiocytosis
Institut de Recherches Internationales Servier
P1/2
CCC
(48)
s241656
Thyroid Gland Carcinoma
Institut de Recherches Internationales Servier
P1/2
CCC
(48)
Sacituzumab
Uterine Cancer
Icahn School of Medicine at Mount Sinai
P1/2
CCC
(48)
Samuraciclib
Pancreatic Adenosquamous Carcinoma
University Health Network, Toronto
P1/2
CCC
(48)
Samuraciclib
Estrogen-Receptor Positive Breast Cancer
Hoffmann-La Roche
P1/2
CCC
(48)
Samuraciclib
Mucinous Adenocarcinoma
University Health Network, Toronto
P1/2
CCC
(48)
Samuraciclib
Malignant Pancreatic Neoplasm
University Health Network, Toronto
P1/2
CCC
(48)
Showing 1751 to 1775 of 6,308 assets
Previous
Page 71 of 253
Next